Dr. Moscow is an oncologist with drug development experience in both academia and in government. He led the Investigational Drug Branch of the Cancer Therapy Evaluation Program at the National Cancer Institute (NCI) before retiring in 2023. Prior to working with NCI in that capacity, he was the Children’s Miracle Network Professor of Pediatrics, Chief of Pediatric Hematology-Oncology, Vice Chair of Pediatrics, and co-leader of the Experimental Therapeutics Program of the Markey Cancer Center at the University of Kentucky. Dr. Moscow is an author of more than 100 peer-reviewed publications and book chapters and has been awarded five patents.